0001127602-20-010513.txt : 20200312 0001127602-20-010513.hdr.sgml : 20200312 20200312201839 ACCESSION NUMBER: 0001127602-20-010513 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200310 FILED AS OF DATE: 20200312 DATE AS OF CHANGE: 20200312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Day Daniel Patrick CENTRAL INDEX KEY: 0001638643 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 20710416 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-03-10 0000882095 GILEAD SCIENCES INC GILD 0001638643 O'Day Daniel Patrick 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 1 Chairman & CEO Non-qualified Stock Option (Right to Buy) 72.34 2020-03-10 4 A 0 256620 0 A 2030-03-10 Common Stock 256620 256620 D Restricted Stock Unit 2020-03-10 4 A 0 43200 A Common Stock 43200 163132 D The shares subject to the option have a four year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The restricted stock units have a four year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested. /s/ Amy Kim by Power of Attorney for Daniel O'Day 2020-03-12